European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection

Elio Ríboli(Centre international de recherche sur le cancer), Kelly J. Hunt(The University of Texas at San Antonio Health Science Center), Nadia Slimani(Centre international de recherche sur le cancer), Pietro Ferrari(Centre international de recherche sur le cancer), T. Norat(Centre international de recherche sur le cancer), Michael Fahey(Centre international de recherche sur le cancer), U. Ruth Charrondière(Centre international de recherche sur le cancer), Bertrand Hémon(Centre international de recherche sur le cancer), Corinne Casagrande(Centre international de recherche sur le cancer), Jérôme Vignat(Centre international de recherche sur le cancer), Kim Overvad(Aarhus University), Anne Tjønneland(Danish Cancer Society), F Clavel-Chapelon(Inserm), Anne C. M. Thiébaut(Inserm), J. Wahrendorf(German Cancer Research Center), Heiner Boeing(German Institute of Human Nutrition), D. Trichopoulos(Harvard University), Antonia Trichopoulou(National and Kapodistrian University of Athens), Paolo Vineis(University of Turin), Domenico Palli(Tumour Institute of Tuscany), HB Bueno-de-Mesquita(National Institute for Public Health and the Environment), PHM Peeters, Eiliv Lund(UiT The Arctic University of Norway), Dagrun Engeset(UiT The Arctic University of Norway), Carlos A. González(Institut Català d'Ornitologia), Aurelio Barricarte(Instituto de Salud Pública de Navarra), G Berglund(Lund University), G. Hallmans(University Hospital of Umeå), NE Day(University of Cambridge), TJ Key(Cancer Research UK), Rudolf Kaaks(Centre international de recherche sur le cancer), Rodolfo Saracci(National Research Council)
Public Health Nutrition
December 1, 2002
Cited by 1,866Open Access
Full Text

Abstract

The European Prospective Investigation into Cancer and Nutrition (EPIC) is an ongoing multi-centre prospective cohort study designed to investigate the relationship between nutrition and cancer, with the potential for studying other diseases as well. The study currently includes 519 978 participants (366 521 women and 153 457 men, mostly aged 35-70 years) in 23 centres located in 10 European countries, to be followed for cancer incidence and cause-specific mortality for several decades. At enrollment, which took place between 1992 and 2000 at each of the different centres, information was collected through a non-dietary questionnaire on lifestyle variables and through a dietary questionnaire addressing usual diet. Anthropometric measurements were performed and blood samples taken, from which plasma, serum, red cells and buffy coat fractions were separated and aliquoted for long-term storage, mostly in liquid nitrogen. To calibrate dietary measurements, a standardised, computer-assisted 24-hour dietary recall was implemented at each centre on stratified random samples of the participants, for a total of 36 900 subjects. EPIC represents the largest single resource available today world-wide for prospective investigations on the aetiology of cancers (and other diseases) that can integrate questionnaire data on lifestyle and diet, biomarkers of diet and of endogenous metabolism (e.g. hormones and growth factors) and genetic polymorphisms. First results of case-control studies nested within the cohort are expected early in 2003. The present paper provides a description of the EPIC study, with the aim of simplifying reference to it in future papers reporting substantive or methodological studies carried out in the EPIC cohort.


Related Papers

No related papers found

Powered by citation graph analysis